Cargando…

Cytomegaloviruses and Macrophages—Friends and Foes From Early on?

Starting at birth, newborn infants are exposed to numerous microorganisms. Adaptation of the innate immune system to them is a delicate process, with potentially advantageous and harmful implications for health development. Cytomegaloviruses (CMVs) are highly adapted to their specific mammalian host...

Descripción completa

Detalles Bibliográficos
Autores principales: Baasch, Sebastian, Ruzsics, Zsolt, Henneke, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235172/
https://www.ncbi.nlm.nih.gov/pubmed/32477336
http://dx.doi.org/10.3389/fimmu.2020.00793
_version_ 1783535907963404288
author Baasch, Sebastian
Ruzsics, Zsolt
Henneke, Philipp
author_facet Baasch, Sebastian
Ruzsics, Zsolt
Henneke, Philipp
author_sort Baasch, Sebastian
collection PubMed
description Starting at birth, newborn infants are exposed to numerous microorganisms. Adaptation of the innate immune system to them is a delicate process, with potentially advantageous and harmful implications for health development. Cytomegaloviruses (CMVs) are highly adapted to their specific mammalian hosts, with which they share millions of years of co-evolution. Throughout the history of mankind, human CMV has infected most infants in the first months of life without overt implications for health. Thus, CMV infections are intertwined with normal immune development. Nonetheless, CMV has retained substantial pathogenicity following infection in utero or in situations of immunosuppression, leading to pathology in virtually any organ and particularly the central nervous system (CNS). CMVs enter the host through mucosal interfaces of the gastrointestinal and respiratory tract, where macrophages (MACs) are the most abundant immune cell type. Tissue MACs and their potential progenitors, monocytes, are established target cells of CMVs. Recently, several discoveries have revolutionized our understanding on the pre- and postnatal development and site-specific adaptation of tissue MACs. In this review, we explore experimental evidences and concepts on how CMV infections may impact on MAC development and activation as part of host-virus co-adaptation.
format Online
Article
Text
id pubmed-7235172
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72351722020-05-29 Cytomegaloviruses and Macrophages—Friends and Foes From Early on? Baasch, Sebastian Ruzsics, Zsolt Henneke, Philipp Front Immunol Immunology Starting at birth, newborn infants are exposed to numerous microorganisms. Adaptation of the innate immune system to them is a delicate process, with potentially advantageous and harmful implications for health development. Cytomegaloviruses (CMVs) are highly adapted to their specific mammalian hosts, with which they share millions of years of co-evolution. Throughout the history of mankind, human CMV has infected most infants in the first months of life without overt implications for health. Thus, CMV infections are intertwined with normal immune development. Nonetheless, CMV has retained substantial pathogenicity following infection in utero or in situations of immunosuppression, leading to pathology in virtually any organ and particularly the central nervous system (CNS). CMVs enter the host through mucosal interfaces of the gastrointestinal and respiratory tract, where macrophages (MACs) are the most abundant immune cell type. Tissue MACs and their potential progenitors, monocytes, are established target cells of CMVs. Recently, several discoveries have revolutionized our understanding on the pre- and postnatal development and site-specific adaptation of tissue MACs. In this review, we explore experimental evidences and concepts on how CMV infections may impact on MAC development and activation as part of host-virus co-adaptation. Frontiers Media S.A. 2020-05-12 /pmc/articles/PMC7235172/ /pubmed/32477336 http://dx.doi.org/10.3389/fimmu.2020.00793 Text en Copyright © 2020 Baasch, Ruzsics and Henneke. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Baasch, Sebastian
Ruzsics, Zsolt
Henneke, Philipp
Cytomegaloviruses and Macrophages—Friends and Foes From Early on?
title Cytomegaloviruses and Macrophages—Friends and Foes From Early on?
title_full Cytomegaloviruses and Macrophages—Friends and Foes From Early on?
title_fullStr Cytomegaloviruses and Macrophages—Friends and Foes From Early on?
title_full_unstemmed Cytomegaloviruses and Macrophages—Friends and Foes From Early on?
title_short Cytomegaloviruses and Macrophages—Friends and Foes From Early on?
title_sort cytomegaloviruses and macrophages—friends and foes from early on?
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235172/
https://www.ncbi.nlm.nih.gov/pubmed/32477336
http://dx.doi.org/10.3389/fimmu.2020.00793
work_keys_str_mv AT baaschsebastian cytomegalovirusesandmacrophagesfriendsandfoesfromearlyon
AT ruzsicszsolt cytomegalovirusesandmacrophagesfriendsandfoesfromearlyon
AT hennekephilipp cytomegalovirusesandmacrophagesfriendsandfoesfromearlyon